Skip to Main Content

Author Details

Gustavo C Rodriguez
Clinica Quirurgica 2 (Surgical Clinic 2), Hospital Maciel
1990
119
50
PMIDPaper TitleJournal TitlePublished Year
36876978Laparoscopic Low Anterior Resection and Total Mesorectal Excision.Dis Colon Rectum2023
36448723Laparoscopic repair of a colovesical fistula secondary to diverticular disease - a video vignette.Colorectal Dis2023
34844992Progestin Significantly Inhibits Carcinogenesis in the Mogp-TAg Transgenic Mouse Model of Fallopian Tube Cancer.Cancer Prev Res (Phila)2022
35663850Surviving and thriving: What do survivors of gynecologic cancer want?Gynecol Oncol Rep2022
35562554Gastro-gastric Fistula: Late Complication After Roux-en-Y Gastric Bypass.Obes Surg2022
35216968Effect of risk-reducing salpingo-oophorectomy on sex steroid hormone serum levels among postmenopausal women: an NRG Oncology/Gynecologic Oncology Group study.Am J Obstet Gynecol2022
34216135Sub-millimeter endoscope demonstrates feasibility of in vivo reflectance imaging, fluorescence imaging, and cell collection in the fallopian tubes.J Biomed Opt2021
34511240Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.Gynecol Oncol2021
34157203Laparoscopic mesh rectopexy in recurrent rectal prolapse - a video vignette.Colorectal Dis2021
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
31759774Prospective follow-up of quality of life for participants undergoing risk-reducing salpingo-oophorectomy or ovarian cancer screening in GOG-0199: An NRG Oncology/GOG study.Gynecol Oncol2020
30312457Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study.J Natl Cancer Inst2019
35116885TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types.Transl Cancer Res2019
32337492Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).JNCI Cancer Spectr2019
31213659Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.Br J Cancer2019
31352365Clinical outcomes in ovarian cancer patients receiving three versus more cycles of chemotherapy after neoadjuvant treatment and interval cytoreductive surgery.Int J Gynecol Cancer2019
31178149Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.Gynecol Oncol2019
31015198Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.Cancer Prev Res (Phila)2019
29446198Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.Hum Mutat2018
30054336A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.Cancer Res2018
27796716Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3.Breast Cancer Res Treat2017
28190649Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.Gynecol Oncol2017
28346442Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.Nat Genet2017
28143870Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.Clin Cancer Res2017
29371931Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP.Oncotarget2017
29058716Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.Nat Genet2017
28708786Venous Thromboembolism in Patients Receiving Extended Pharmacologic Prophylaxis After Robotic Surgery for Endometrial Cancer.Int J Gynecol Cancer2017
25940428No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.Gynecol Oncol2016
27769055Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1.Oncotarget2016
27601076Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.Nat Commun2016
27433858Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study.Menopause2016
27106018Progestins inhibit calcitriol-induced CYP24A1 and synergistically inhibit ovarian cancer cell viability: An opportunity for chemoprevention.Gynecol Oncol2016
25336561Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev2015
25838164Patterns and utility of routine surveillance in high grade endometrial cancer.Gynecol Oncol2015
25830658Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.PLoS One2015
25849179Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.JAMA2015
25581431Identification of six new susceptibility loci for invasive epithelial ovarian cancer.Nat Genet2015
25070663Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGFβ pathway.Cancer Prev Res (Phila)2014
25919761Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers.Breast Cancer Res2014
25199754Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.J Clin Oncol2014
23136228Prospective analysis of vitamin D and endometrial cancer risk.Ann Oncol2013
24136864Evidence of a chemopreventive effect of progestin unrelated to ovulation on reproductive tract cancers in the egg-laying hen.Cancer Prev Res (Phila)2013
23682076Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells.Cancer Prev Res (Phila)2013
23535731Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer.Nat Genet2013
23544013Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.PLoS Genet2013
22343225Ovarian cancer: etiology, risk factors, and epidemiology.Clin Obstet Gynecol2012
22729394A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.Cancer Epidemiol Biomarkers Prev2012
22206747Nonsteroidal antiinflammatory drugs and progestins synergistically enhance cell death in ovarian epithelial cells.Am J Obstet Gynecol2012
21093898Comparison of gene expression patterns between avian and human ovarian cancers.Gynecol Oncol2011
21893500Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.Cancer Prev Res (Phila)2011
  • 1 - 50 of 119

Recommended Authors

Yingmei Wang
Tianjin Medical University General Hospital
Career Start Year 2007
Number of shared co-authors 0
Shin-Wha Lee
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 1
Divya Gupta
Emory University School of Medicine
Career Start Year 2006
Number of shared co-authors 2
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 32
Maria Del Pilar Estevez Diz
Instituto do Cancer do Estado de Sao Paulo and Universidade de Sao Paulo
Career Start Year 2002
Number of shared co-authors 0
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 22
Blaise A Clarke
University of Toronto.
Career Start Year 2001
Number of shared co-authors 51
Aparna A Kamat
Houston Methodist Hospital
Career Start Year 2000
Number of shared co-authors 3
Steve E Kalloger
University of British Columbia
Career Start Year 2000
Number of shared co-authors 31
Kathleen M Schmeler
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 3
Kevin Holcomb
Weill Cornell Medical College
Career Start Year 1996
Number of shared co-authors 3
Alison Brand
Westmead Hospital
Career Start Year 1995
Number of shared co-authors 124
Paulette Mhawech-Fauceglia
University of Southern California
Career Start Year 1995
Number of shared co-authors 15
Yong-Man Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year 1994
Number of shared co-authors 2
Annette Hasenburg
University Medical Center, Johannes Gutenberg University Mainz
Career Start Year 1994
Number of shared co-authors 4
Denise C Connolly
Fox Chase Cancer Center
Career Start Year 1993
Number of shared co-authors 10
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 2
Barry R Davies
Oncology R&D
Career Start Year 1992
Number of shared co-authors 7
Anil K Sood
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 40
Rosemarie Schmandt
The University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 5
Patricia A Shaw
Princess Margaret Cancer Centre, University Avenue
Career Start Year 1990
Number of shared co-authors 45
Fr??d??ric Amant
Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 72
Lora H Ellenson
Memorial Sloan Kettering Cancer Center
Career Start Year 1989
Number of shared co-authors 2
Philippe Gauthier
Boston University
Career Start Year 1985
Number of shared co-authors 0
Ossama Tawfik
University of Kansas
Career Start Year 1985
Number of shared co-authors 2
Stefan Aebi
University of Bern
Career Start Year 1985
Number of shared co-authors 3
John A Copland
Mayo Clinic Jacksonville
Career Start Year 1982
Number of shared co-authors 7
Ronny Drapkin
University of Pennsylvania School of Medicine
Career Start Year 1980
Number of shared co-authors 80
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 6
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 4

Collaborators

Andrew Berchuck
Duke School of Medicine
Co-authored papers 47
Susan M Domchek
Co-authored papers 25
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 25
Javier Ben??tez
Instituto de Salud Carlos III
Co-authored papers 24
Irene L Andrulis
University of Toronto
Co-authored papers 23
Fergus J Couch
Mayo Clinic
Co-authored papers 23
Douglas F Easton
University of Cambridge
Co-authored papers 23
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Co-authored papers 22
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Co-authored papers 22
David E Goldgar
University of Utah
Co-authored papers 22
Amanda B Spurdle
QIMR Berghofer Medical Research Institute
Co-authored papers 19
Jan Lubinski
Pomeranian Medical University
Co-authored papers 19
Mary Beth Terry
Co-authored papers 19
Beth Y Karlan
David Geffen School of Medicine, University of California los angeles
Co-authored papers 19
Ana Osorio
Familial Cancer Clinical Unit, Spanish National Cancer Research Centre
Co-authored papers 19
Judy E Garber
Dana-Farber Cancer Institute
Co-authored papers 18
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 18
Timothy R Rebbeck
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Co-authored papers 17
Siranoush Manoukian
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 17
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 16
Sue Healey
QIMR Berghofer Medical Research Institute
Co-authored papers 16
Claudine Isaacs
Co-authored papers 16
Louise Izatt
Guy's and St Thomas' NHS Foundation Trust
Co-authored papers 15
Jenny Lester
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 15
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 15
Esther M John
Co-authored papers 15
George L Maxwell
Women's Health Integrated Research Center, Inova Health System
Co-authored papers 14
Robert L Nussbaum
Invitae Corporation
Co-authored papers 13
Noralane M Lindor
Mayo Clinic
Co-authored papers 12
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 11
Release 1.2